Ultralife Corp (ULBI) stock
Close on Nov 12, 2026Market cap $262.95MP/E –Yield –
Ultralife Corp grew revenue 3.0% to $192.14M over the twelve months to Sep 30, 2026. Operating income fell 168.0% to -$4.20M, moving the operating margin from 3.3% to -2.2%. Free cash flow was -$694.00K, down 107.8% from a year earlier. At the latest close the market valued the company at $262.95M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $262.95M
- P/E ratio
- –
- Price to sales
- 1.37
- Price to book
- 1.95
- Dividend yield
- –
- Free cash flow yield
- -0.26%
Fundamentals
- Revenue
- $192.14M
- Net income
- -$2.96M
- EPS, diluted
- -$35.00
- Free cash flow
- -$694.00K
- Book value per share
- $8.06
- Diluted shares
- 17M
Trading
- Next earnings
- Mar 9, 2027 (estimated, during market hours)
- Previous close
- $15.75
- Open
- $15.72
- Day's range
- $15.72 – $15.80
- Volume
- 93,103
- Average volume (20 days)
- 298,967
- Beta (5 years)
- 0.85
- 52-week range
- $4.90 – $15.83
- RSI (14 days)
- 92.8
- Volatility (1 year)
- 155.3%
- Relative volume
- 0.80×
- WACC
- 8.5%
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ULBI | S&P 500 | Difference | ULBI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +154.9% | -2.7% | +157.6 pts | ||
| 3 months | +118.6% | -1.7% | +120.3 pts | ||
| Year to date | +175.9% | +11.9% | +164.0 pts | ||
| 1 year | +174.0% | +12.0% | +162.0 pts | ||
| 3 years | +107.9% | +78.2% | +29.7 pts | +27.6% | +21.2% |
| 5 years | +175.9% | +73.2% | +102.6 pts | +22.5% | +11.6% |
| 10 years | +271.3% | +309.6% | −38.4 pts | +14.0% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Ultralife filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Results
- Results
About Ultralife
Miscellaneous Electrical Machinery, Equipment & Supplies
Ultralife Corporation designs, manufactures, and markets power and communications systems worldwide. The company operates through two main business segments: Battery & Energy Products and Communications Systems. Its battery offerings include non-rechargeable lithium cells, customized rechargeable battery packs, and charging systems used across diverse commercial, medical, and industrial sectors. Its communications segment provides radio-frequency amplifiers, power supplies, cable assemblies, and integrated vehicle-mounted or man-portable communication setups. Customers include commercial manufacturers, defense contractors, retail consumers, and government defense departments globally.
Company profile, executives and historyUltralife stock: common questions
What is Ultralife's stock price?
ULBI closed at $15.78 on Nov 12, 2026, up 0.19% on the day. Over the past 52 weeks it traded between $4.90 and $15.83.
What is Ultralife's market cap?
Ultralife was worth $262.95M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is ULBI's P/E ratio?
Ultralife lost money over fiscal 2025 (diluted EPS -$35.00), so it has no meaningful P/E ratio.
How much revenue does Ultralife make?
Ultralife reported revenue of $192.14M for the twelve months to Sep 30, 2026, up 3.0% from a year earlier.
Does Ultralife pay a dividend?
No. Ultralife has not paid a cash dividend over the last twelve months.
When does Ultralife report earnings next?
Ultralife is expected to report Q4 FY2026 results on Mar 9, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has ULBI stock performed over the past year?
Including dividends, ULBI returned +174.0% over the past year, against +12.0% for the S&P 500.
How many ULBI shares are sold short?
0M shares were sold short at the latest FINRA report, 0.66% of the float, or 1.0 days of average trading volume.
Who are Ultralife's competitors?
Companies most similar to Ultralife by business, industry and size include CBAT, AMPX, MVST, NRGV, ELVA.
See a number that looks wrong?